BCG 009
Alternative Names: BCG-009Latest Information Update: 29 Jun 2023
At a glance
- Originator Beijing Biocytogen
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 12 May 2023 Early research in Unspecified in China (Parenteral) (Beijing Biocytogen pipeline, May 2023)